• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
ARAY

ARAY

Accuray Incorporated

NASDAQHealthcareMedical - DevicesUS
Rating:C-

Company Profile

CEO

Stephen R. LaNeve

IPO Date

2007-02-08

Sector

Healthcare

Industry

Medical - Devices

Exchange

NASDAQ

Country

US

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

30.9%

Avg Negative

2.5%

Avg Neutral

66.7%

News Feed

Mika Nishimura Joins Accuray Board of Directors

PRNewsWire·8/23/2021·↓ negative

Accuray Incorporated (ARAY) CEO Josh Levine on Q4 2021 Results - Earnings Call Transcript

Seeking Alpha·8/11/2021·↓ negative

Accuray (ARAY) Reports Q4 Loss, Tops Revenue Estimates

Zacks Investment Research·8/11/2021·↑ positive

Accuray (ARAY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

Zacks Investment Research·8/4/2021·↑ positive

Hong Kong Sanatorium & Hospital Transforms Cancer Care in Asia with Treatment of First Patient Using the Accuray Radixact® System and ClearRT™ Helical Fan-Beam kVCT Imaging

PRNewsWire·7/22/2021·↑ positive

Beloved Family Pet's Lung Cancer is Treated with Targeted Radiotherapy Using the Accuray Radixact® System with Synchrony® Technology

PRNewsWire·6/24/2021·↑ positive

Accuray Announces Promotion of Suzanne Winter to President

PRNewsWire·6/22/2021·↓ negative

Accuray's (ARAY) CyberKnife Gets Support From RayStation TPS

Zacks Investment Research·6/18/2021·↑ positive

Accuray Expands CyberKnife® System Versatility with Integration of RaySearch's RayStation Treatment Planning System

PRNewsWire·6/16/2021·↑ positive

Accuray (ARAY) Expands Commercialization of CE-Marked ClearRT

Zacks Investment Research·6/14/2021·↑ positive